Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
Clinical trial NCT01230138 · COMPLETED
Trial details
- NCT number
- NCT01230138
- Sponsor
- Forward-Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.